why choose us

First received: August 18, 2022

Clinical Trial: A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL

Study Status: Completed

Recruit Status: RECRUITING

Condition: Lymphoma, Non-Hodgkin

Study Type: INTERVENTIONAL


Official Title: A Phase I, Open-label, Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ONO-7018 in Patients With Relapsed or Refractory NHL or CLL

Brief Summary: This is a Phase 1, open-label, multicenter study.This will be the first-in-human clinical study for ONO-7018 and will be conducted in two phases: a Dose Escalation Phase (Part 1) and a Dose Expansion Phase (Part 2).

Read more